50.97
0.99 (1.98%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Korro Bio, Inc. | Bearish | - |
Stockmoo Score
|
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Qiming U.S. Ventures Management, Llc | 30 Jun 2024 | 368,085 |
| 72 Investment Holdings, Llc | 30 Jun 2024 | 276,831 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 100.00 (HC Wainwright & Co., 96.19%) | Buy |
| Median | 97.50 (91.29%) | |
| Low | 95.00 (RBC Capital, 86.38%) | Buy |
| Average | 97.50 (91.29%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 39.71 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 14 Aug 2024 | 100.00 (96.19%) | Buy | 39.71 |
| RBC Capital | 14 Aug 2024 | 95.00 (86.38%) | Buy | 39.71 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 16 Sep 2024 | Announcement | Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates |
| 10 Sep 2024 | Announcement | Korro to Participate in Upcoming Investor Conferences |
| 28 Aug 2024 | Announcement | Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors |
| 27 Aug 2024 | Announcement | Korro to Participate in Upcoming September Investor and Scientific Conferences |
| 13 Aug 2024 | Announcement | Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates |
| 01 Jul 2024 | Announcement | Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |